Patent | Date |
---|
Compositions And Methods For Acutely Raising Nitic Oxide Levels App 20220296552 - Tripp; Matthew L. ;   et al. | 2022-09-22 |
Phytocomplexes exhibiting multiple, synergistic antioxidant activities useful in foods, dietary supplements, cosmetics and pharmaceutical preparations Grant 11,331,363 - Tripp , et al. May 17, 2 | 2022-05-17 |
Compositions and methods for acutley raising nitric oxide levels Grant 11,241,406 - Tripp , et al. February 8, 2 | 2022-02-08 |
Methods and compositions to improve weight loss and cardiometabolic health beyond diet and excercise Grant 11,122,832 - Tripp , et al. September 21, 2 | 2021-09-21 |
Methods And Compositions To Enhance Metabolic Detoxification Systems App 20210038656 - Tripp; Matthew L. ;   et al. | 2021-02-11 |
Phytocomplexes Exhibiting Multiple, Synergistic Antioxidant Activities Useful In Foods, Dietary Supplements, Cosmetics And Pharm App 20200246412 - Kind Code | 2020-08-06 |
Phytocomplexes exhibiting multiple, synergistic antioxidant activities useful in foods, dietary supplements, cosmetics and pharmaceutical preparations Grant 10,434,131 - Tripp , et al. O | 2019-10-08 |
Methods And Compositions To Improve Weight Loss And Cardiometabolic Health Beyond Diet And Excercise App 20190261669 - Tripp; Matthew L. ;   et al. | 2019-08-29 |
Phosphodiesterase-4 inhibiting phytochemical compositions Grant 10,179,155 - Tripp , et al. Ja | 2019-01-15 |
Compositions And Methods For Acutley Raising Nitric Oxide Levels App 20180263944 - Tripp; Matthew L. ;   et al. | 2018-09-20 |
Phosphodiesterase Inhibiting Phytochemical Compositions App 20170065653 - Tripp; Matthew L. ;   et al. | 2017-03-09 |
Phosphodiesterase-4 Inhibiting Phytochemical Compositions App 20170065652 - Tripp; Matthew L. ;   et al. | 2017-03-09 |
Phytocomplexes Exhibiting Multiple, Synergistic Antioxidant Activities Useful In Foods, Dietary Supplements, Cosmetics And Pharmaceutical Preparations App 20170020948 - Tripp; Matthew L. ;   et al. | 2017-01-26 |
Compositions that treat or inhibit pathological conditions associated with inflammatory response Grant 8,557,306 - Tripp , et al. October 15, 2 | 2013-10-15 |
Compositions that treat or inhibit pathological conditions associated with inflammatory response Grant 8,486,457 - Tripp , et al. July 16, 2 | 2013-07-16 |
Anti-inflammatory Botanical Products For The Treatment Of Metabolic Syndrome And Diabetes App 20130064913 - Tripp; Matthew L. ;   et al. | 2013-03-14 |
Compositions That Treat Or Inhibit Pathological Conditions Associated With Inflammatory Response App 20120270837 - Tripp; Matthew L. ;   et al. | 2012-10-25 |
Protein kinase modulation by hops and Acacia products Grant 8,263,139 - Tripp , et al. September 11, 2 | 2012-09-11 |
Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response Grant 8,257,754 - Tripp , et al. September 4, 2 | 2012-09-04 |
Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response App 20120183634 - Tripp; Matthew L. ;   et al. | 2012-07-19 |
Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response App 20120177756 - Tripp; Matthew L. ;   et al. | 2012-07-12 |
Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes Grant 8,206,753 - Tripp , et al. June 26, 2 | 2012-06-26 |
Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines Grant 8,193,201 - Babish , et al. June 5, 2 | 2012-06-05 |
Compositions that treat or inhibit pathological conditions associated with inflammatory response Grant 8,168,234 - Tripp , et al. May 1, 2 | 2012-05-01 |
Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response Grant 8,142,819 - Tripp , et al. March 27, 2 | 2012-03-27 |
Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines Grant 8,092,846 - Babish , et al. January 10, 2 | 2012-01-10 |
Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology Grant 8,093,292 - Pacioretty , et al. January 10, 2 | 2012-01-10 |
Formulations containing thymoquinone for urinary health Grant 8,029,831 - Pacioretty , et al. October 4, 2 | 2011-10-04 |
Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia Grant 8,017,651 - Pacioretty , et al. September 13, 2 | 2011-09-13 |
Synergistic Anti-inflammatory Pharmaceutical Compositions And Related Methods Using Curcuminoids Or Methylxanthines App 20110172253 - Babish; John G. ;   et al. | 2011-07-14 |
Modulation of inflammation by hops fractions and derivatives Grant 7,919,125 - Tripp , et al. April 5, 2 | 2011-04-05 |
Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines Grant 7,914,831 - Babish , et al. March 29, 2 | 2011-03-29 |
Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops Grant 7,901,713 - Tripp , et al. March 8, 2 | 2011-03-08 |
Modulation Of Inflammation By Hops Fractions And Derivatives App 20110021638 - Tripp; Matthew L. ;   et al. | 2011-01-27 |
Xanthohumol And Tetrahydro-isoalpha Acid Based Protein Kinase Modulation Cancer Treatment App 20110021637 - Tripp; Matthew L. ;   et al. | 2011-01-27 |
Modulation of inflammation by hops fractions and derivatives Grant 7,820,206 - Tripp , et al. October 26, 2 | 2010-10-26 |
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity Grant 7,815,944 - Babish , et al. October 19, 2 | 2010-10-19 |
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity Grant 7,807,203 - Babish , et al. October 5, 2 | 2010-10-05 |
Modulation of inflammation by hops fractions and derivatives Grant 7,794,757 - Tripp , et al. September 14, 2 | 2010-09-14 |
Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response Grant 7,790,205 - Tripp , et al. September 7, 2 | 2010-09-07 |
Novel Mitochondrial Uncoupling Methods And Compositions For Enhancing Adipocyte Thermogenesis App 20100215782 - Babish; John G. ;   et al. | 2010-08-26 |
Anti-inflammatory Pharmaceutical Compositions For Reducing Inflammation And The Treatment Or Prevention Of Gastric Toxicity App 20100184857 - Babish; John G. ;   et al. | 2010-07-22 |
Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment Grant 7,736,677 - Tripp , et al. June 15, 2 | 2010-06-15 |
Substituted 1,3-cyclopentadione Multi-target Protein Kinase Modulators Of Cancer, Angiogenesis And The Inflammatory Pathways Associated Therewith App 20100137449 - Tripp; Matthew L. ;   et al. | 2010-06-03 |
Modulation of inflammation by hops fractions and derivatives Grant 7,722,903 - Tripp , et al. May 25, 2 | 2010-05-25 |
Phytochemical Compositions And Methods For Activating Amp-kinase App 20100112099 - Tripp; Matthew L. ;   et al. | 2010-05-06 |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 Grant 7,682,636 - Babish , et al. March 23, 2 | 2010-03-23 |
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity Grant 7,666,449 - Babish , et al. February 23, 2 | 2010-02-23 |
Formulations containing thymoquinone for urinary health App 20100028468 - Pacioretty; Linda M. ;   et al. | 2010-02-04 |
Compositions Exhibiting Inhibition Of Cyclooxygenase-2 App 20090274778 - Babish; John G. | 2009-11-05 |
Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2 App 20090263522 - Babish; John G. ;   et al. | 2009-10-22 |
Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops App 20090118373 - Tripp; Matthew L. ;   et al. | 2009-05-07 |
Protein Kinase Modulation by Hops and Acacia Products App 20080248131 - Tripp; Matthew L. ;   et al. | 2008-10-09 |
Compositions that treat or inhibit pathological conditions associated with inflammatory response Grant 7,431,948 - Tripp , et al. October 7, 2 | 2008-10-07 |
Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology App 20080114065 - Pacioretty; Linda M. ;   et al. | 2008-05-15 |
Isoalpha acid based protein kinase modulation cancer treatment App 20080051466 - Tripp; Matthew L. ;   et al. | 2008-02-28 |
Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment App 20080051465 - Tripp; Matthew L. ;   et al. | 2008-02-28 |
Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 Grant 7,332,185 - Babish , et al. February 19, 2 | 2008-02-19 |
Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment App 20080031982 - Tripp; Matthew L. ;   et al. | 2008-02-07 |
Protein kinase modulation by hops and acacia products App 20080031986 - Tripp; Matthew L. ;   et al. | 2008-02-07 |
Beta acid based protein kinase modulation cancer treatment App 20080031894 - Tripp; Matthew L. ;   et al. | 2008-02-07 |
Xanthohumol based protein kinase modulation cancer treatment App 20080033056 - Tripp; Matthew L. ;   et al. | 2008-02-07 |
Acacia based protein kinase modulation cancer treatment App 20080031893 - Tripp; Matthew L. ;   et al. | 2008-02-07 |
Hexahydro-isoalpha acid based protein kinase modulation cancer treatment App 20080033057 - Tripp; Matthew L. ;   et al. | 2008-02-07 |
Reduced isoalpha acid based protein kinase modulation cancer treatment App 20080026088 - Tripp; Matthew L. ;   et al. | 2008-01-31 |
Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes App 20070281045 - Tripp; Matthew L. ;   et al. | 2007-12-06 |
Synergistic Anti-Inflammatory Pharmaceutical Compositions and Methods of Use App 20070249728 - Babish; John G. ;   et al. | 2007-10-25 |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 Grant 7,279,185 - Babish , et al. October 9, 2 | 2007-10-09 |
Compositions that treat or inhibit pathological conditions associated with inflammatory response Grant 7,270,835 - Tripp , et al. September 18, 2 | 2007-09-18 |
Compositions that treat or inhibit pathological conditions associated with inflammatory response App 20070184133 - Tripp; Matthew L. ;   et al. | 2007-08-09 |
Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines App 20070185213 - Babish; John G. ;   et al. | 2007-08-09 |
Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 App 20070172532 - Babish; John G. ;   et al. | 2007-07-26 |
Compositions that treat or inhibit pathological conditions associated with inflammatory response App 20070160692 - Tripp; Matthew L. ;   et al. | 2007-07-12 |
Protein kinase modulation by hops and Acacia products App 20070154576 - Tripp; Matthew L. ;   et al. | 2007-07-05 |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 App 20070141183 - Babish; John G. ;   et al. | 2007-06-21 |
Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 Grant 7,205,151 - Babish , et al. April 17, 2 | 2007-04-17 |
Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 Grant 7,195,785 - Babish , et al. March 27, 2 | 2007-03-27 |
Protein kinase modulation by hops and acacia products App 20070042063 - Tripp; Matthew L. ;   et al. | 2007-02-22 |
Modulation of inflammation by hops fractions and derivatives App 20060193933 - Tripp; Matthew L. ;   et al. | 2006-08-31 |
Compositions that treat or inhibit pathological conditions associated with inflammatory response App 20060177531 - Tripp; Matthew L. ;   et al. | 2006-08-10 |
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity App 20060141082 - Babish; John G. ;   et al. | 2006-06-29 |
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity App 20060141081 - Babish; John G. ;   et al. | 2006-06-29 |
Modulation of inflammation by hops fractions and derivatives App 20060127512 - Tripp; Matthew L. ;   et al. | 2006-06-15 |
Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response App 20060127514 - Tripp; Matthew L. ;   et al. | 2006-06-15 |
Modulation of inflammation by hops fractions and derivatives App 20060127511 - Tripp; Matthew L. ;   et al. | 2006-06-15 |
Modulation of inflammation by hops fractions and derivatives App 20060127516 - Tripp; Matthew L. ;   et al. | 2006-06-15 |
Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response App 20060127513 - Tripp; Matthew L. ;   et al. | 2006-06-15 |
Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response App 20060127515 - Tripp; Matthew L. ;   et al. | 2006-06-15 |
Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response App 20060127517 - Tripp; Matthew L. ;   et al. | 2006-06-15 |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 Grant 6,979,470 - Babish , et al. December 27, 2 | 2005-12-27 |
Arginine compositions for coordinate modification of multiple cardiovascular risk factors App 20050233944 - Babish, John G. | 2005-10-20 |
Synergistic anti-inflammatory pharmaceutical compositions and methods of use App 20050192356 - Babish, John G. ;   et al. | 2005-09-01 |
Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines App 20050191375 - Babish, John G. ;   et al. | 2005-09-01 |
Combinations of sesquiterpene lactones and ditepene triepoxide lactones for synergistic inhibition of cyclooxygenase-2 Grant 6,908,630 - Babish , et al. June 21, 2 | 2005-06-21 |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 App 20050129791 - Babish, John G. ;   et al. | 2005-06-16 |
Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 App 20050042317 - Babish, John G ;   et al. | 2005-02-24 |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 App 20040247700 - Babish, John G. ;   et al. | 2004-12-09 |
Methods for determining the activity of complex mixtures App 20040235063 - Babish, John G. ;   et al. | 2004-11-25 |
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity App 20040219240 - Babish, John G. ;   et al. | 2004-11-04 |
Methods for determining the activity of complex mixtures Grant 6,780,596 - Babish , et al. August 24, 2 | 2004-08-24 |
Compositions that treat or inhibit pathological conditions associated with inflammatory response App 20040151792 - Tripp, Matthew L. ;   et al. | 2004-08-05 |
Modulation of inflammation by hops fractions and derivatives App 20040115290 - Tripp, Matthew L. ;   et al. | 2004-06-17 |
Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia App 20040106591 - Pacioretty, Linda M. ;   et al. | 2004-06-03 |
Oral composition with insulin-like activities and methods of use Grant 6,733,793 - Pacioretty , et al. May 11, 2 | 2004-05-11 |
Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response App 20040086580 - Tripp, Matthew L. ;   et al. | 2004-05-06 |
Oral composition with insulin-like activities and methods of use App 20030224061 - Pacioretty, Linda M. ;   et al. | 2003-12-04 |
Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect App 20030206972 - Babish, John G. ;   et al. | 2003-11-06 |
Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 Grant 6,629,835 - Babish , et al. October 7, 2 | 2003-10-07 |
Characterized E2IG3 protein for diagnosis and treatment of proliferative diseases App 20030170740 - Hatzis, Christos ;   et al. | 2003-09-11 |
Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes App 20030124548 - Hatzis, Christos ;   et al. | 2003-07-03 |
Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 App 20030113393 - Babish, John G. ;   et al. | 2003-06-19 |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 App 20030108628 - Babish, John G. ;   et al. | 2003-06-12 |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 App 20030096027 - Babish, John G. ;   et al. | 2003-05-22 |
Arginine compositions for coordinate modification of multiple cardiovascular risk factors App 20030054978 - Babish, John G. | 2003-03-20 |
Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 App 20030008021 - Babish, John G. ;   et al. | 2003-01-09 |
Combinations of psyllium and chitosan for synergistic adsorption of triglyceride App 20020137729 - Babish, John G. | 2002-09-26 |
Compositions containing tryptamines, cartenoids and tocotrienols and having synergistic antioxidant effect App 20020120001 - Babish, John G. ;   et al. | 2002-08-29 |
Composition exhibiting synergistic antioxidant activity App 20020110604 - Babish, John G. ;   et al. | 2002-08-15 |
Combinations of sesquiterpene lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 App 20020076452 - Babish, John G. ;   et al. | 2002-06-20 |
Combinations of sesquiterpene lactones and ditepene triepoxide lactones for synergistic inhibition of cyclooxygenase-2 App 20020077299 - Babish, John G. ;   et al. | 2002-06-20 |
Compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2 App 20020077350 - Babish, John G. ;   et al. | 2002-06-20 |
Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 App 20020068098 - Babish, John G. ;   et al. | 2002-06-06 |
Methods For Determining The Activity Of Complex Mixtures App 20010039022 - BABISH, JOHN G. ;   et al. | 2001-11-08 |
Use of the AH receptor and AH receptor ligands to treat or prevent cytopathicity of viral infection Grant 5,833,994 - Wheelock , et al. November 10, 1 | 1998-11-10 |
Automated, multicompartmental cell culture system Grant 5,612,188 - Shuler , et al. March 18, 1 | 1997-03-18 |
Immunoassay for AH receptor transformed by dioxin-like compounds Grant 5,529,899 - Wheelock , et al. June 25, 1 | 1996-06-25 |
Indirect immunoassay for dioxinlike compounds Grant 5,496,703 - Babish , et al. March 5, 1 | 1996-03-05 |
Use of metallic salts of pyridine-2-thione-N-oxide to treat or prevent swine exudative epidermitis Grant 4,399,130 - Davidson , et al. August 16, 1 | 1983-08-16 |